New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2014
09:35 EDTPODDInsulet price target raised to $43 from $35 at Stephens
Stephens raised its price target on Insulet to $43 following the company's Q4 report and FY14 guidance, but says it views the shares as fairly valued and maintains its Equal Weight rating on the stock.
News For PODD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
11:02 EDTPODDInsulet Q2 postponement may indicate an acquisition is near, says Feltl
As previously reported, Feltl upgraded Insulet to Hold from Sell. Analyst Ben Haynor believes the surprising preliminary Q2 release and postponement of full results is odd behavior and may indicate an "acquisition may be afoot." Haynor increased his price target on Insulet to $35 based upon the multiple St. Jude (STJ) is paying to acquire Thoratec (THOR).
10:45 EDTPODDInsulet upgraded to Hold from Sell at Feltl
July 29, 2015
19:36 EDTPODDInsulet working 'expeditiously' to complete full Q2 results
Subscribe for More Information
19:35 EDTPODDInsulet backs FY15 revenue guidance of $305M-$320M, consensus $302.65M
Subscribe for More Information
19:35 EDTPODDInsulet sees Q3 revenue $82M-$85M, consensus $83.6M
19:34 EDTPODDInsulet reports preliminary Q2 revenue $75.6M, consensus $68.95M
Subscribe for More Information
19:33 EDTPODDInsulet postpones release fo full Q2 results
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use